Stock ISOFOL ISOFOL MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Isofol Medical AB

Equities

ISOFOL

SE0009581051

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
0.688 SEK -0.58% Intraday chart for Isofol Medical AB 0.00% -5.75%
Jun. 12 Isofol Medical Starts Search for New CFO MT
Jun. 12 Isofol Medical AB Announces That Magnus Hurst, Chief Financial Officer to Leave the Company, Effective from September 2, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Isofol Medical Starts Search for New CFO
MT
Isofol's Chief Financial Officer to leave the company
AQ
Isofol Medical AB Announces That Magnus Hurst, Chief Financial Officer to Leave the Company, Effective from September 2, 2024
CI
Isofol and Charité sign collaboration agreement on further clinical development of arfolitixorin
AQ
Bulletin from annual general meeting in Isofol Medical AB (publ) held on May 8, 2024
AQ
Isofol Medical () : publishes interim report, January-March 2024
PU
Isofol Medical AB (publ) publishes interim report, January–March 2024
AQ
Isofol Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023
AQ
Notice to attend the Annual General Meeting held on May 8, 2024 in Isofol Medical AB (publ)
AQ
Isofol Medical : Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin
PU
Isofol’s Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin
AQ
Isofol presents a clinical development plan for arfolitixorin
AQ
Isofol Medical : invites to investor meeting on March 19
PU
Isofol Medical AB (publ) publishes year-end report, January - December 2023
AQ
Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Isofol's Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19
AQ
Isofol Medical Hires New CFO
MT
Isofol appoints Magnus Hurst as new Chief Financial Officer
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ISOFOL Stock
  4. News Isofol Medical AB